Courtney M. Lappas
Associate Professor Biology
Meier, B. P. & Lappas, C. M. (2016). The influence of safety, efficacy, and medical condition severity on natural versus synthetic drug preference. Medical Decision Making, 36(8), 1011-1019.
Lappas, C. M. (2015). The immunomodulatory effects of titanium dioxide and silver nanoparticles. Food and Chemical Toxicology, 85, 78-83.
Lappas, N. T., & Lappas, C. M. (2016). Forensic Toxicology: Principles and concepts. Cambridge, Mass.: Academic Press.
Lappas, C. M. (2014). The immunotoxicology of nanomaterials. In S. Sahu, & D. Casciano (Eds.), Handbook of nanotoxicology, nanomedicine and stem cell use in toxicology (pp. 99-110). New York, NY: John Wiley & Sons.
Lappas, C. M. (2014, May 12). The plant hormone Zeatin Riboside inhibits T lymphocyte activity via Adenosine A2A receptor activation. Cellular & Molecular Immunology, doi:10.1038/cmi.2014.33
Meier, B. P., Fetterman, A. K., Robinson, M. D., & Lappas, C. M. (2015). The myth of the angry atheist.Journal of Psychology, 149, 219-238. doi:10.1080/00223980.2013.866929
Lappas, C. M. (2012). D-limonene modulates T lymphocyte activity and viability. Cellular Immunology, 279, 30-41.
Weilnau, J. N., Black, S. E., Chehata, V. J., Schmidt, M. P., Holt, K. L., Carl, L. M., . . . Lappas, C. M. (2013). ZnS nanocrystal cytotoxicity is influenced by capping agent chemical structure and duration of time in suspension. Journal of Applied Toxicology, 33, 227-237.
Lappas, C. M., & Lappas, N. T. (2012). D-limonene modulates T lymphocyte activity and viability. Cellular Immunology, 279,30-41. doi: https://linkinghub.elsevier.com/retrieve/pii/S0008874912001669
Weilnau, J. N., Black, S. E., Chehata, V. J., Schmidt, M. J., Holt, K. L., Carl, L.M., Straka, C. J, Marsh, A. L., Patton, W. A., Lappas, C. M. (2012). ZnS nanocrystal cytotoxicity is influenced by capping agent chemical structure and duration of time in suspension. Journal of Applied Toxicology, doi:10.1002/jat.2811
Chehata, V. J., Domeier, P. P., Weilnau, J. N., & Lappas, C. M. (2011). Adenosine A2A receptor activation limits chronic granulomatous disease-induced hyperinflammation. Cellular Immunology, 267(1), 39-49. doi:10.1016/j.cellimm.2010.11.002
Lappas, C. M. (2012). Allogenic hematopoietic stem cell transplantation followed by graft-versus-host disease: Role of adenosine A2A receptor. In M. A. Hayat (Ed.), Stem cells and cancer stem cells: Therapeutic applications in disease and injury (pp. 149-155). New York: Springer. doi:10.1007/978-94-007-1709-1_18